Effect

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Zuk, Aleksandra ^a   Fitzpatrick, Tiffany ^b   Rosella, Laura C ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; COLECALCIFEROL; HEMOGLOBIN A1C; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; TUMOR NECROSIS FACTOR; VITAMIN;

ARTICLE; COCHRANE LIBRARY; DRUG EFFECT; EMBASE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; MEDLINE; OBESITY; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ADULT; ANALYSIS; BLOOD; COMPLICATION; IMMUNOLOGY; OVERWEIGHT; RANDOMIZED CONTROLLED TRIAL (TOPIC); VITAMIN D DEFICIENCY;

ADULT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLECALCIFEROL; HUMANS; INFLAMMATION; OBESITY; OVERWEIGHT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D DEFICIENCY; VITAMINS;

EID: 85015606373     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154215     Document Type: Article

References (100)

1. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. The American journal of the medical sciences. 2006; 331(4):166-74. PMID: 16617231
2. Guh D, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis A. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health. 2009; 9(1):88.
3. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002; 288(14):1723-7. PMID: 12365955
4. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss an update of the 1997 American Heart Association Scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation. 2006; 113(6):898-918. PMID: 16380542
5. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed). 1984; 289(6454):1257.
6. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. The Journal of Clinical Investigation. 2011; 121(6):2111-7. doi: 10.1172/JCI57132 PMID: 21633179
7. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011; 29:415-45. doi: 10.1146/annurev-immunol-031210-101322 PMID: 21219177
8. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342(12):836-43. PMID: 10733371
9. de Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012; 71(02):332-8.
10. Levine TB, Levine AB. Inflammation. Metabolic Syndrome and Cardiovascular Disease, Second Edition. 2006:192-227.
11. Dandona P, Ghanim H, Mohanty P, Chaudhuri A. The metabolic syndrome: Linking oxidative stress and inflammation to obesity, type 2 diabetes, and the syndrome. Drug development research. 2006; 67(7):619-26.
12. Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444(7121):881-7. PMID: 17167477
13. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes. 2003; 52(7):1779-85. PMID: 12829646
14. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006; 83(2):461S-5S. PMID: 16470013
15. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005; 96 (9):939-49. PMID: 15890981
16. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Critical Reviews™ in Immunology. 2012;32(1).
17. Manigrasso M, Ferroni P, Santilli F, Taraborelli T, Guagnano M, Michetti N, et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. The Journal of Clinical Endocrinology & Metabolism. 2005; 90(10):5876-9.
18. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2007; 92 (6):2017-29.
19. Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutrition research reviews. 2009; 22(01):82-92.
20. Kositsawat J, Freeman VL, Gerber BS, Geraci S. Association of A1C Levels With Vitamin D Status in US Adults Data from the National Health and Nutrition Examination Survey. Diabetes Care. 2010; 33 (6):1236-8. doi: 10.2337/dc09-2150 PMID: 20215453
21. Forouhi NG, Luan Ja, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance the medical research council ely prospective study 1990-2000. Diabetes. 2008; 57(10):2619-25. doi: 10.2337/db08-0593 PMID: 18591391
22. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117(4):503-11. doi: 10.1161/CIRCULATIONAHA. 107.706127 PMID: 18180395
23. Barker T, Martins TB, Hill HR, Kjeldsberg CR, Dixon BM, Schneider ED, et al. Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults. Eur J Appl Physiol. 2013; 113(6):1523-34. doi: 10.1007/s00421-012-2582-7 PMID: 23292315
24. Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25 (OH) D concentrations in healthy women. J Inflamm (Lond). 2008; 5:10.
25. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 2011; 57(1):63-9. doi: 10.1161/HYPERTENSIONAHA.110.160929 PMID: 21115878
26. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. The Journal of Clinical endocrinology & metabolism. 2009; 94(10):4023-30.
27. Schwalfenberg G. Not enough vitamin D Health consequences for Canadians. Can Fam Physician. 2007; 53(5):841-54. PMID: 17872747
28. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. The American journal of clinical nutrition. 2008; 87(4):1080S-6S. PMID: 18400738
29. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014; 384(9945):766-81.
30. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9. PMID: 19622511
31. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesityrelated health risk. The American journal of clinical nutrition. 2004; 79(3):379-84. PMID: 14985210
32. WHO EC. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. PMID: 14726171
33. Al-Badr W, Martin KJ. Vitamin D and kidney disease. Clin J Am Soc Nephrol. 2008; 3(5):1555-60. doi: 10.2215/CJN.01150308 PMID: 18450926
34. Whyte MP, Haddad JR JG, Walters DD, Stamp TC. Vitamin D Bioavailability: Serum 25-Hydroxyvitamin D Levels in Man after Oral, Subcutaneous, Intramuscular, and Intravenous Vitamin D Administration&z.ast;. The Journal of Clinical Endocrinology & Metabolism. 1979; 48(6):906-11.
35. Cipriani C, Romagnoli E, Pepe J, Russo S, Carlucci L, Piemonte S, et al. Long-Term Bioavailability After a Single Oral or Intramuscular Administration of 600,000 IU of Ergocalciferol or Cholecalciferol: Implications for Treatment and Prophylaxis. The Journal of Clinical Endocrinology & Metabolism. 2013; 98(7):2709-15.
36. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005; 37(5):360-3. PMID: 15883903
37. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977:159-74. PMID: 843571
38. Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005; 85(3):257-68. PMID: 15733050
39. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343.
40. Littell JH, Corcoran J, Pillai V. Systematic reviews and meta-analysis. 2008.
41. Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012; 60(3):870-4. doi: 10.1016/j.cyto.2012.07.032 PMID: 22925537
42. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med. 2010; 267 (5):462-72. doi: 10.1111/j.1365-2796.2009.02181.x PMID: 20141565
43. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Gøransson LG, Omdal R. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine. 2010; 50(2):175-80. doi: 10.1016/j.cyto.2009.12.006 PMID: 20122848
44. Carrillo AE, Flynn MG, Pinkston C, Markofski MM, Jiang Y, Donkin SS, et al. Vitamin D supplementation during exercise training does not alter inflammatory biomarkers in overweight and obese subjects. Eur J Appl Physiol. 2012; 112(8):3045-52. doi: 10.1007/s00421-011-2279-3 PMID: 22183086
45. Carrillo AE, Flynn MG, Pinkston C, Markofski MM, Jiang Y, Donkin SS, et al. Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adults. Clin Nutr. 2013; 32(3):375-81. doi: 10.1016/j.clnu. 2012.08.014 PMID: 23034474
46. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007; 30 (4):980-6. PMID: 17277040
47. Wamberg L, Kampmann U, Stødkilde-Jørgensen H, Rejnmark L, Pedersen S, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels-results from a randomized trial. Eur J Intern Med. 2013; 24 (7):644-9. doi: 10.1016/j.ejim.2013.03.005 PMID: 23566943
48. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. The American journal of clinical nutrition. 2009; 89(5):1321-7. doi: 10.3945/ajcn.2008.27004 PMID: 19321573
49. Nagpal J, Pande J, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009; 26(1):19-27. doi: 10.1111/j.1464-5491.2008.02636.x PMID: 19125756
50. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013; 36(2):260-6. doi: 10.2337/dc12-1204 PMID: 23033239
51. Harris S, Pittas A, Palermo N. A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes, Obesity and Metabolism. 2012; 14(9):789-94. doi: 10.1111/j.1463-1326.2012.01605.x PMID: 22486948
52. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. The American journal of clinical nutrition. 2011; 94(2):486-94. doi: 10.3945/ajcn.111.011684 PMID: 21715514
53. Zhu W, Cai D, Wang Y, Lin N, Hu Q, Qi Y, et al. Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: a randomized controlled trial. Nutrition journal. 2013; 12:8. doi: 10.1186/1475-2891-12-8 PMID: 23297844
54. Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Lawless A. Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference. Int J Food Sci Nutr. 2011; 62(04):318-27.
55. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011; 96(1):53-8. doi: 10.1210/jc.2010-2704 PMID: 21118827
56. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2011; 96(7):1911-30.
57. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. The Lancet. 2002; 359(9306):614-8.
58. Verhagen AP, de Vet HC, de Bie RA, Boers M, van den Brandt PA. The art of quality assessment of RCTs included in systematic reviews. J Clin Epidemiol. 2001; 54(7):651-4. PMID: 11438404
59. Dumville JC, Torgerson DJ, Hewitt CE. Research methods: reporting attrition in randomised controlled trials. BMJ: British Medical Journal. 2006; 332(7547):969. PMID: 16627519
60. Akl EA, Briel M, You JJ, Sun X, Johnston BC, Busse JW, et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ. 2012; 344:e2809. doi: 10.1136/bmj.e2809 PMID: 22611167
61. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997; 337(10):670-6. PMID: 9278463
62. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). The American journal of cardiology. 2012; 109(2):226-30. doi: 10.1016/j.amjcard.2011.08.032 PMID: 21996139
63. Sun X, Cao Z-B, Zhang Y, Ishimi Y, Tabata I, Higuchi M. Association between serum 25-hydroxyvitamin D and inflammatory cytokines in healthy adults. Nutrients. 2014; 6(1):221-30. doi: 10.3390/ nu6010221 PMID: 24451309
64. Dalgård C, Petersen MS, Weihe P, Grandjean P. Vitamin D status in relation to glucose metabolism and type 2 diabetes in septuagenarians. Diabetes Care. 2011; 34(6):1284-8. doi: 10.2337/dc10-2084 PMID: 21515843
65. Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br J Nutr. 2012; 108(11):1915-23. doi: 10.1017/S0007114512003285 PMID: 23046765
66. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. PMID: 17634462
67. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. The American journal of clinical nutrition. 2000; 72(3):690-3. PMID: 10966885
68. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. The Journal of Clinical Endocrinology & Metabolism. 2004; 89(3):1196-9.
69. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2010; 59(1):242-8. doi: 10.2337/ db09-1011 PMID: 19833894
70. Ryden M, Arner P. Tumour necrosis factor-α in human adipose tissue-from signalling mechanisms to clinical implications. J Intern Med. 2007; 262(4):431-8. PMID: 17875179
71. Cawthorn WP, Sethi JK. TNF-α and adipocyte biology. FEBS Lett. 2008; 582(1):117-31. PMID: 18037376
72. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract. 2005; 69(1):29-35. PMID: 15955385
73. Ding C, Wilding JP, Bing C. 1, 25-dihydroxyvitamin D 3 Protects against Macrophage-Induced Activation of NFκB and MAPK Signalling and Chemokine Release in Human Adipocytes. PLoS One. 2013; 8(4):e61707. doi: 10.1371/journal.pone.0061707 PMID: 23637889
74. Rytka JM, Wueest S, Schoenle EJ, Konrad D. The portal theory supported by venous drainage-selective fat transplantation. Diabetes. 2011; 60(1):56-63. doi: 10.2337/db10-0697 PMID: 20956499
75. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008; 29(24):2959-71. doi: 10.1093/eurheartj/ehn387 PMID: 18775919
76. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007; 56(4):1010-3. PMID: 17287468
77. Olszanecka-Glinianowicz M, Chudek J, Kocełak P, Szromek A, Zahorska-Markiewicz B. Body fat changes and activity of tumor necrosis factor α system-a 5-year follow-up study. Metabolism. 2011; 60(4):531-6. doi: 10.1016/j.metabol.2010.04.023 PMID: 20580040
78. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J, Zurakowski A. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-α and TNF soluble receptors in women with overweight and obesity. Metabolism. 2004; 53(10):1268-73. PMID: 15375781
79. Winkler G, Kiss S, Keszthelyi L, Sápi Z, Ory I, Salamon F, et al. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. European Journal of Endocrinology. 2003; 149(2):129-35. PMID: 12887290
80. Bellia A, Garcovich C, D'Adamo M, Lombardo M, Tesauro M, Donadel G, et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med. 2013; 8(1):33-40. doi: 10.1007/s11739-011-0559-x PMID: 21437585
81. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier M-C. Vitamin D and inflammation. Joint Bone Spine. 2010; 77(6):552-7. doi: 10.1016/j.jbspin.2010.09.018 PMID: 21067953
82. Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, et al. Effects of 25-hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod. 2006; 75 (6):816-22. PMID: 16957024
83. Díaz L, Noyola-Martínez N, Barrera D, Hernández G, Avila E, Halhali A, et al. Calcitriol inhibits TNF-αinduced inflammatory cytokines in human trophoblasts. J Reprod Immunol. 2009; 81(1):17-24. doi: 10.1016/j.jri.2009.02.005 PMID: 19501915
84. Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. 1α, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine. 2009; 45(3):190-7. doi: 10.1016/j.cyto.2008.12.009 PMID: 19186073
85. Alkharfy KM, Al-Daghri NM, Yakout SM, Ahmed M. Calcitriol Attenuates Weight-Related Systemic Inflammation and Ultrastructural Changes in the Liver in a Rodent Model. Basic Clin Pharmacol Toxicol. 2013; 112(1):42-9. doi: 10.1111/j.1742-7843.2012.00936.x PMID: 22905919
86. Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2014; 43(1):205-32. doi: 10.1016/j.ecl.2013.09.010 PMID: 24582099
87. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. The American journal of clinical nutrition. 2004; 79(5):820-5. PMID: 15113720
88. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014; 348:g2035. doi: 10.1136/bmj.g2035 PMID: 24690624
89. Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc. 2013; 72 (01):89-97.
90. Kong J, Chen Y, Zhu G, Zhao Q, Li YC. 1, 25-Dihydroxyvitamin D3 upregulates leptin expression in mouse adipose tissue. J Endocrinol. 2013; 216(2):265-71. doi: 10.1530/JOE-12-0344 PMID: 23160964
91. de Oliveira Leal V, Mafra D. Adipokines in obesity. Clin Chim Acta. 2013; 419:87-94. doi: 10.1016/j. cca.2013.02.003 PMID: 23422739
92. Penckofer S, Kouba J, Wallis DE, Emanuele MA. Vitamin D and Diabetes Let the Sunshine In. The Diabetes Educator. 2008; 34(6):939-54. doi: 10.1177/0145721708326764 PMID: 19075078
93. Mitri J, Muraru M, Pittas A. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011; 65(9):1005-15. doi: 10.1038/ejcn.2011.118 PMID: 21731035
94. Heaney RP. Vitamin D-Baseline status and effective dose. N Engl J Med. 2012; 367(1):77-8. doi: 10.1056/NEJMe1206858 PMID: 22762324
95. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. The American journal of clinical nutrition. 2004; 79(3):362-71. PMID: 14985208
96. Field AE, Camargo CA, Ogino S. The Merits of Subtyping Obesity: One Size Does Not Fit All. JAMA. 2013; 310(20):2147-8. doi: 10.1001/jama.2013.281501 PMID: 24189835
97. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis J. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ: British Medical Journal. 2014;348.
98. Bigby M, Williams H. Appraising systematic reviews and meta-analyses. Arch Dermatol. 2003; 139 (6):795-8. PMID: 12810513
99. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. The Cochrane Library. 2012.
100. Tricco AC, Tetzlaff J, Sampson M, Fergusson D, Cogo E, Horsley T, et al. Few systematic reviews exist documenting the extent of bias: a systematic review. J Clin Epidemiol. 2008; 61(5):422-34. doi: 10.1016/j.jclinepi.2007.10.017 PMID: 18394534